Frankfurt Session 4: Take the next step: How to thrive outside of academia with your scientific background
May
31
7:00 pm19:00

Frankfurt Session 4: Take the next step: How to thrive outside of academia with your scientific background

  • Goethe University | PEG 1.G192

Welcome to SIUConversations! In our speaker series we invite renowned experts from various fields of industry and academia, who will share insides into their personal career trajectories. Our aim is to inform students and early researchers (PhD, PostDocs) of diverse career possibilities through the examples of our speakers. After each talk, the audience will have the chance to get to know the speakers and organizers in an informal wine and cheese setting.

Our speaker for this event will be Dr. Patrick Britz.
Are you considering starting a company or working for an existing company with the skills you gained during your PhD?

If yes, come and join this exciting session to listen to Patrick Britz who turned the company Brain Vision into a leading distributor for neuroimaging equipment and a reliable partner for many research labs around the world.

In this talk he will share his own success path with us by giving valuable information on:

-        How to prepare yourself for a career outside of academia

-        What to pay attention to when you are applying for a job

-        How to use your scientific knowledge to create a company

-        What are the highs, lows and mistakes of creating a company in the research market

Patrick is the CEO & President of Brain Vision LLC and the Marketing Director at Brain Products GmbH. He also holds a PhD degree in Biopsychology. During his PhD, he started working for Brain Vision as a scientific consultant and not long afterwards was promoted to President of Brain Vision thanks to his problem-solving skills and commitment to providing solutions to Neuroscientists. 

Frankfurt Session 5: Brain on, dude! Working at the interface of science, communication and media.
Jun
7
7:00 pm19:00

Frankfurt Session 5: Brain on, dude! Working at the interface of science, communication and media.

  • Goethe University | PEG 1.G192

Welcome to SIUConversations! In our speaker series we invite renowned experts from various fields of industry and academia, who will share insides into their personal career trajectories. Our aim is to inform students and early researchers (PhD, PostDocs) of diverse career possibilities through the examples of our speakers. After each talk, the audience will have the chance to get to know the speakers and organizers in an informal wine and cheese setting.

Our speaker for this event will be Dr. Henning Beck.
Henning Beck started his doctorate at the Hertie Institute for Clinical Brain Research in Tübingen in 2008 and finished it at the Institute of Physiological Chemistry at the University of Ulm eventually receiving his PhD from the Graduate School of Cellular and Molecular Neuroscience in Tübingen. Not long after finishing his doctorate, Dr. Beck also completed his international Diploma in Project Management at the University of California Berkeley.

Since 2011, he has been traveling Germany as a "Science Slammer" eventually going on to win the German Nationals for his lecture on “Speed up your mind”. Dr. Beck continues to give lectures, workshops, and performances in which he breaks down the complicated issues of neuroscience in an understandable and entertaining manner to audiences around Germany. Dr. Beck is a regular contributor to GEO-Magazine and Wirtschaftswoche where he comments on the newest trends in brain science.

Additionally, he has authored multiple books in which he explains complicated issues in an understandable and engaging way. In his latest book, published earlier this year, "Irren ist nützlich. Warum die Schwächen des Gehirns unsere Stärken sind", he discusses why we are so often distracted, find it difficult to concentrate, or easily forget things. More importantly, he tells us why these supposed deficiencies may not be such a problem at all. Dr. Beck has been able to artfully explain complicated science to a wider audience in his TEDxTalk, contributions to Wired-magazine or SWR-television.

To find out more about Dr. Beck's latest book, as well as what is like to transition from the world of academia to a successful speaker and author join us at the SIU seminar series.

SIUFocus London: Brexit - The Divorce Battle over Life Sciences and Funding
Jun
8
7:00 pm19:00

SIUFocus London: Brexit - The Divorce Battle over Life Sciences and Funding

  • LGS, Imperial College Business School, South Kensington Campus

On June 23, 2016, the United Kingdom voted to leave the European Union in what could either be described as a catastrophic self-destruction or a glorious grasp at independence. Wrapped up in a state of confusion over their status in the United Kingdom are scientists from Europe and abroad. 

Despite the constant reassurance from academia and industry about scientists’ current status, scientists are worried about what would happen to their jobs and funding after the UK officially leaves the EU in 2019. Will the scientific sector in the UK suffer from less funding from Europe? Will scientists in the EU and abroad flock to other countries such as France or Germany? What type of incentive system should the UK set up in order to continue to attract the greatest minds from around the world?

These are a few of a multitude of questions that will be addressed during this session to understand the direction Brexit will take science in the UK.

GUEST SPEAKERS: BETH THOMPSON, KIMBERLY CORNFIELD, MICHAEL BROWNE

LGS, Imperial College Business School, South Kensington Campus, London, SW7 2AZ

The event will proceed as follows:
19:00-19:20 Beth Thompson, Policy Adviser, Wellcome Trust
19:20-19:40 Kimberly Cornfield, Head of Proposal Management, University College London
19:40-20:00 Michael Browne, Head of European Research & Innovation, University College London
20:00-20:20 Q&A and panel discussion

Frankfurt Session 6: From Experimentation to Eco-Innovation: How to Start a Start-Up
Jun
28
7:00 pm19:00

Frankfurt Session 6: From Experimentation to Eco-Innovation: How to Start a Start-Up

  • Goethe University | PEG 1.G192

In this session SIU members will learn how they can translate an innovative technology emerged from their academic research into a successful start-up company.

They will get a deep insight into the skills needed to start a business, how to set the business plan, how to find initial funding and how all this is possible while doing your PhD.

 

Our guest speakers are Dipl.-Ing. Sascha Knauer and Dr.-Ing. Christina Uth.


Frankfurt Session 3: How I plan to revolutionise artificial intelligence by capitalising on decades of scientific research
May
17
7:00 pm19:00

Frankfurt Session 3: How I plan to revolutionise artificial intelligence by capitalising on decades of scientific research

  • Goethe University | PEG 1.G192

You like doing research, but how about applications? Is it possible to do both at the same time? In this talk you can learn from an expert who achieved this already. Come and join us to learn from Prof. Christoph von der Malsburg.

GUEST SPEAKER: DR. CHRISTOPH VON DER MALSBURG

GOETHE UNIVERSITY | PEG 1.G192, THEODOR-W. ADORNO-PLATZ 6 (7:00 PM TO 9:00 PM)

Dr. Christoph von der Malsburg is Senior Fellow at the Frankfurt Institute for Advanced Studies (FIAS) since 2007. He received his PhD in physics from the University of Heidelberg, Germany, and CERN in Geneva. Subsequently, he joined the section of Neurobiology of the Max-Planck-Institute for Biophysical Chemistry in Göttingen, before becoming Professor of Computer Science, Neuroscience, Physics and Psychology at the University of Southern California in Los Angeles.

Eventually, Professor von der Malsburg returned to Germany as a Professor of Systems Biophysics at the Ruhr University Bochum where he founded the Institut für Neuroinformatik together with Werner von Seelen. In 1997, he co-founded the company ZN Vision, which develops face recognition technology now under the name L 1 Identity Solutions AG in Bochum, and the company Eyematic, the core of which is now part of Google.

Among a number of prestigious awards (IEEE Pioneer Award 1994, Beckurts Foundation Award 1998, Hebb Award 2003), Professor von der Malsburg received the Körber European Science Prize in 2000 for his innovative contributions to the perception of shape in technology with insights from nature. He is a renowned pioneer in his field, studying the processes of self-organisation in the visual system and the creator of the Dynamic Link Architecture. He recently founded the company Platonite.

Katowice Session 2: The Revolution of Surgery and The Rise of Technology
May
16
5:00 pm17:00

Katowice Session 2: The Revolution of Surgery and The Rise of Technology

  • A3 lecture hall, Medical University of Silesia, Medyków 18, Katowice 40-752, Poland

Do you realise how FAST technology is shaping the future of medicine?
Our biggest tool now sits in our pockets and desks as mobile phones and tablets.

Join us on May 16th to discuss the history and the future of surgery, in collaboration with MEDtube.

GUEST SPEAKER: PIOTR BAŃKA, COMMUNICATIONS MANAGER, MEDTUBE 

A3 LECTURE HALL, MEDICAL UNIVERSITY OF SILESIA (5:00 PM - 6:30 PM)

MEDtube is an online video-centric education and communication platform for healthcare professionals, originally created by Polish transplantologists in 2010. The online library contains medical videos, images, medical cases, visualisations and animations, as well as other professional materials, encompassing all medical specialties. The materials are shared by physicians, medical societies, universities and other institutions all over the world, from Poland to the USA.

Oxford Session 4: Meet the CEO
May
15
5:30 pm17:30

Oxford Session 4: Meet the CEO

  • New Biochemistry

Come join this exciting session to meet three Oxford alumni and early career researchers who turned their brilliant concepts into reality. These entrepreneurs will each share their stories about how they developed their ideas and turned them into successful businesses. After a series of short flash presentations from each CEO, the session will move on to a panel discussion, where you can ask your own specific questions to the panellists. Come and find out how to progress your career from a student to CEO.

GUEST SPEAKERS: RIHAM SATTI, EKATERINA DAMER AND JOHN STUART

NEW BIOCHEMISTRY BUILDING, SOUTH PARKS RD, OX1 3QU - (5:30PM TO 7.30PM)

Riham Satti CEO of MeVitae, an AI decision-making platform in the human capital sector, is amongst the top disruptive game changers in Thames Valley and top tech business leaders. She works with some of the most innovative tech companies around the world.

Ekaterina Damer is the CEO of Prolific. In her own words: "Prolific is the most fun, fair, and efficient participant recruitment platform for scientists and startups. We've bootstrapped our startup to £1M in sales with zero marketing spend and without having raised investment (yet)". 

John Stuart is the founder and CEO of Bounts Limited. Bounts is a digital health platform that aims to motivate people to keep committed to a healthy life. After 6 years and £1.5m investment, John has been through all the highs, lows and mistakes of creating a company from scratch.

Frankfurt Session 2: ‚We‘: The social identity approach to effective leadership
May
10
7:00 pm19:00

Frankfurt Session 2: ‚We‘: The social identity approach to effective leadership

  • Goethe University | PEG 1.G192

Want to learn how to be a leader and how to manage people while working in groups? These are the skills you should have as a researcher and we have the best tips for you from an expert in the field! Join us and learn from Prof. Rolf Van Dick.
During his talk in the SIU seminar series Prof Van Dick hopes to present insights about identity and leadership as well as his own experiences working with companies.

GUEST SPEAKER: PROFESSOR ROLF VAN DICK

GOETHE UNIVERSITY | PEG 1.G192, THEODOR-W. ADORNO-PLATZ 6 (7:00 PM TO 9:00 PM)

Professor van Dick started his psychology career at Philipps-University Marburg where he earned his PhD under the supervision of Ulrich Wagner. Following his time in Marburg, Professor van Dick became first a senior lecturer and eventually a full professor at Aston University in Birmingham, England.

In 2006, he returned to Germany as the chair for Social Psychology at the Goethe-University. Additionally, he has been a visiting professor at several universities across the world and as of 2016 he holds and additional professorship at the Work Research Institute in Oslo, Norway. Rolf van Dick is co-founder and Scientific Director of the Center for Leadership and Behavior in Organizations (CLBO) at Goethe University.

He is an internationally renowned expert for inter- and intra- group processes, identity, diversity, and leadership.He has also worked on such topics as stress and job satisfaction. Professor van Dick, is not only a profound researcher, but also well-loved among the Frankfurt psychology students as a two-time winner of the YAVIS award for outstanding teaching. 

Cambridge Session 4: Meet the Founder, Pitch Perfect
Apr
28
10:30 pm22:30

Cambridge Session 4: Meet the Founder, Pitch Perfect

  • Department of Engineering

Come listen to pitch-structured presentations by successful biomedical start-ups based in Cambridge. These companies are excited to share how they managed to launch a business from a scientific idea and will discuss their background, current project and future directions.

GUEST SPEAKERS: SIMON LAMBDEN, SU METCALFE, ATTILA CSORDAS, PORTIA ASLI 

DEPARTMENT OF ENGINEERING, UNIVERSITY OF CAMBRIDGE (7-9 PM)

Dr Simon Lambden is part of the academic intensive care team of the University. He will present his experience in launching and securing funding for his new start-up based on a new treatment for sepsis, a life threatening condition that arises when the body’s response to infection causes injury to its own tissues. He will address the issue of convincing private sector funders to invest in a novel idea.

Su Metcalfe is the founder and CSO of LifNano Therapeutics. LIFNanoRx is a nano-bio-med company focused on treatment of Multiple Sclerosis (MS), an auto-immune inflammatory disease of the central nervous system. Using a critical stem cell factor with unique biological properties alongside nanoparticle technology, they present a new approach to the treatment of MS.

Attila Csordas is the founder AgeCurve, a startup with a vision to provide deep molecular age profiles for every grown-up. They believe that the complexity of ageing can be captured reliably by detecting molecular patterns and analysing big chunks of people’s proteome from saliva, to learn and to assess lifestyle interventions.

Portia Asli is the chief commercial officer of Vocalens, a Cambridge University spin-out startup co-founded by Cambridge engineers and MBAs, developing smart wearable assistive technology for people with visual impairment.

The Power of Big Data: Advancing Healthcare in the Electronic Era
Apr
27
6:30 pm18:30

The Power of Big Data: Advancing Healthcare in the Electronic Era

  • JZ Young Lecture Theatre Anatomy Building

The field of computational biology has seen dramatic growth over the past few years. The significant advances in computing power are now being used to conduct data analytics, mathematical modelling and computational simulation, for an ever-increasingly diverse set of problems. With applications in genomics, neuroscience and medicine, we look to gain an understanding of its future implications with the emergence of Artificial Intelligence and Machine Learning and how this will disrupt and revolutionise both medicine and healthcare.

Frankfurt Session 1: Academia's bittersweet box of chocolates: (Tr)eat with caution!
Apr
19
7:00 pm19:00

Frankfurt Session 1: Academia's bittersweet box of chocolates: (Tr)eat with caution!

  • Goethe University | PEG 1.G192

Do you want to hear some insider tips on how to become a professor at a young age? Come and join our first SIU session in Frankfurt and get some advice from Prof Melissa Vo. 

Professor Vo will share with SIU members how she managed to become a successful scientist, what she sees as difficulties in that carrier choice and how to handle them, while maintaining the ever illusive life-work balance.

GUEST SPEAKER: PROFESSOR MELISSA VO

GOETHE UNIVERSITY | PEG 1.G192, THEODOR-W. ADORNO-PLATZ 6 (7:00 PM TO 9:00 PM)

Melissa Vo is the head of the Scene Grammar Lab at the Goethe University. Before becoming a professor in Frankfurt, she earned her PhD in Psychology from LMU in her home town of Munich. After her PhD she went on to work at the University of Edinburgh and Harvard University. During her whole carrier she has been maintaining a keen interest in visual cognition and particularly scene perception.

After her time at Harvard University, Professor Vo received the coveted Emmy Noether Grant from the German Research Foundation. In 2014 she returned to Germany as a professor in Cognitive Psychology at Goethe University Frankfurt as the youngest professor in the department. In her first year in Frankfurt she was awarded the YAVIS award for outstanding teaching. Additionally, she is an active member of SciMento – a mentoring program targeted at talented female PhD students and postdocs from 5 universities in Hessen.

Alternative Careers: A Panel Discussion with Naturejobs
Apr
10
5:00 pm17:00

Alternative Careers: A Panel Discussion with Naturejobs

  • New Biochemistry

Science Innovation Union is pleased to welcome Naturejobs editor Jack Leeming for a panel discussion that will focus on alternative careers for scientists. The key points of this interactive session will be the current career trends for scientists in the UK, a comparison of these trends with the rest of the developed world, the ability of scientists to translate their own ideas into independent careers in industry and academia and the risks and advantages to be aware of when making decisions.

One of Jack's main duties at Nature Publishing Group is running the Naturejobs blog. The blog aims to be the leading online resource for scientists in academia and industry who seek guidance in developing their careers.  It delivers a mix of expert advice with personal stories to help readers review, set and achieve their career goals.

The event will also include the awards ceremony for the writing competition SIU held in partnership with Naturejobs and finish with a drinks and networking session. 

London Session 4: Taking Ownership of Your Big Idea: How to Get a Patent
Mar
23
6:30 pm18:30

London Session 4: Taking Ownership of Your Big Idea: How to Get a Patent

  • Chandler House

In biotech, like in many sectors, patents are used to increase the potential return of an investment, defend an idea from competitors and bring benefit to a business. In the final session of the Spring 2017 series, our speaker will introduce what an IP is, how to obtain them, and how businesses in the biotech sphere can use them to maximum effect.

GUEST SPEAKER: LUCY WILLIAMS

CHANDLER HOUSE, 2 WAKEFIELD STREET, LONDON WC1N 1PF (6.30PM TO 8PM)

Dr. Lucy Williams, European Patent Attorney, J A Kemp

After obtaining her PhD in developmental biology from University of Cambridge, Lucy decided to become a patent attorney. She chose J A Kemp because of the size and diversity of the firm itself and its Biotechnology and Life Sciences Group.  

As a patent attorney Lucy has a variety of roles. Some of her responsibilities include acting as an intermediary between clients and patent examiners, patent prosecution and drafting new applications and oppositions. 

https://www.linkedin.com/in/lucy-williams-41367133/

Oxford Session 4: Meet the CEO
Mar
21
6:00 pm18:00

Oxford Session 4: Meet the CEO

  • New Biochemistry

Come join this exciting session to meet three Oxford alumni and early career researchers who turned their brilliant concepts into reality. These three entrepreneurs will each share their stories about how they developed their ideas and turned them into successful businesses. After a series of short flash presentations from each CEO, the session will move on to a panel discussion, where you can ask your own specific questions to the panellists. Come and find out how to progress your career from a student to CEO.

GUEST SPEAKERS: CATHERINE BOTTRILL, EKATERINA DAMER AND JOHN STUART

NEW BIOCHEMISTRY BUILDING, SOUTH PARKS RD, OX1 3QU - (6PM TO 8.00PM)

Catherine Bottrill is founder and CEO of Pilio, an energy analytic software-as-a-service company. Pilio brings cutting-edge energy analytics and innovation to those with responsibility for reducing energy use in buildings. Pilio's clients include: Royal Albert Hall, St. Paul's Cathedral, Whitbread, YMCA and Scottish Power. Pilio was named virtual company of the year at Imperial College Innovation when in the Climate-KIC programme. Catherine was one of 12 women on the 2016 Angel Academe for women in tech supported by the City of London.

Ekaterina Damer is the CEO and co-founder of Prolific Academic Ltd. In Ekaterina's words: "Prolific is the most fun, fair and efficient participant recruitment platform for scientists and startups. We've bootstrapped our startup to £1 million in sales with zero marketing spend and without having raised investment (yet)."

https://www.linkedin.com/in/ekaterina-damer-7158263a/

John Stuart is the founder and CEO of Bounts Limited. Bounts is a digital health platform that aims to motivate people to keep committed to a healthy life. After 6 years and £1.5m investment, John has been through all the highs, lows and mistakes of creating a company from scratch.

https://www.linkedin.com/in/johnkstuart/

Katowice Session 1: How Startups Can Revolutionise Diagnoses and Treatments
Mar
21
5:30 pm17:30

Katowice Session 1: How Startups Can Revolutionise Diagnoses and Treatments

  • A3 lecture hall

As a student or a healthcare professional, do you feel that you  often get lost in the patient's history and struggle for differential diagnosis?
This session will aim to educate on how academia and the healthcare industry can combine to translate knowledge from the patient's history into a probable diagnosis using a clinical support tool. This will be an interactive session, looking at medical case studies and solving problems. Attendees will also be able to explore the possible career options in medicine with a Q&A session. Entrance is free, however to be in the chance of winning a stethoscope from a random draw, raffle tickets can be purchased at 1zl each. Light refreshments will be provided.

GUEST SPEAKER: Dr. Tessa Davis, Clinical Fellow at Chelsea and Westminster Hospital, NHS Foundation Trust

A3 lecture hall, Medical University of Silesia (5:30 PM - 7:00 PM)

Dr. Tessa Davis is a Paediatrician specialising in Paediatric Emergency Medicine. She creates and delivers online learning resources for healthcare professionals. Tessa is passionate about the use of social networks and technology to improve patient care. She is a media commentator for child health issues and speaks about paediatrics and technology at conferences all over the world. Tessa is currently working in London.

In 2015 Tessa won the NSW Minister for Health Registrar of the Year Award.

London Session 3: ACADEMIA AND BIOTECH: THE ENTREPRENEURIAL SCIENTIST
Mar
13
6:00 pm18:00

London Session 3: ACADEMIA AND BIOTECH: THE ENTREPRENEURIAL SCIENTIST

  • CHANDLER HOUSE

In this talk participants will learn how they can spin out their research into a biotech company without having to leave their academic research behind.

Professor Hans Stauss, Director, Institute of Immunity and Transplantation, UCL.

Professor Hans Stauss was an early trail blazer in the field of cancer immunotherapy demonstrating how modified T cells could be used to effectively target tumours. Recognising the medical potential of this research Hans was involved in setting up Cell Medica which is now advancing an impressive pallet of innovative proprietary technologies in the field of immune cell therapy for cancer and viral infections. Meanwhile Hans continues to turn out cutting edge research and is involved in a number of clinical trials.

Oxford Session 3: Insight into Entrepreneurship
Mar
13
5:30 pm17:30

Oxford Session 3: Insight into Entrepreneurship

  • New Biochemistry

Leah Thompson is the curator of Enterprising Oxford, which aims to signpost you to everything Oxford offers in supporting students and staff to become more entrepreneurial. Leah will explore and highlight some of the opportunities for engaging at any point along your journey to be an entrepreneur. Anne Miller will share her experiences in running the MPLS Enterprise programme, which provides all sorts of training and networking activities that increase researchers enterprise skills. They will be joined by successful entrepreneurs who have benefitted from engaging in these programmes.  Come and help us to understand what else would help to create a really vibrant and thriving Entrepreneurial culture here throughout Oxford.

GUEST SPEAKERS: LEAH THOMPSON, ANNE MILLER

NEW BIOCHEMISTRY BUILDING, SOUTH PARKS RD, OX1 3QU - (5:30 PM TO 7.30PM)

 

 

 

London Session 2: Using Your Bioscience Skills to Impact Policy Decisions
Mar
2
6:30 pm18:30

London Session 2: Using Your Bioscience Skills to Impact Policy Decisions

  • Room 802, UCL IOE (Institute of Education)

This talk will focus on using your knowledge in research to the advantage of the public by affecting policies. Particularly, the focus will be on what skills you have achieved in your bioscience studies that are required by governments to help them implement policies. Attendees will thus explore the possible career options available in policy making, and how research is often used in the process of policy making in order to form them with a knowledge and evidence based background.

GUEST SPEAKER: ALESSANDRO ALLEGRA

Room 802, UCL IOE (Institute of Education), 20 Bedford Way, WC1H 0AL - (6.30PM TO 8PM)

After graduating in History and Philosophy of Science from the London School of Economics, Alessandro has worked in UK and international science policy at the UN Educational, Scientific and Cultural Organisation (UNESCO), the Royal Society, and the Royal Society of Biology.

Alessandro is currently pursuing doctoral research at UCL on the use of scientific evidence in policymaking, and collaborates with national and international science policy organisations on a number of projects. He is a board member and Secretary of Association of Italian Scientists in UK (AIS-UK).

https://www.linkedin.com/in/alessandro-allegra-12a6134a/

Oxford Session 2: Inspiring Innovation: Bringing Academia and Industry Together at the Royal Society
Mar
1
6:00 pm18:00

Oxford Session 2: Inspiring Innovation: Bringing Academia and Industry Together at the Royal Society

  • New Biochemistry

We are very happy and excited to welcome Dr Katy Gearing and Dr Alasdair Taylor of the Royal Society to Oxford and the SIU. Katy and Alasdair are doing great work in the area of science innovation and entrepreneurship, and will be running a focus group with a small group of students (see below for details) and giving a talk that is open for all SIU members to attend.

The Royal Society’s Science, Industry and Translation programme aims to reinvigorate the links between the Society and industry, and promote the importance of translating research into new products, processes and companies with societal and economic impacts. In this talk, Katy and Alasdair will describe some of the Society’s current work and the insights it has given them into technology transfer, entrepreneurship, emerging technologies and science careers in industry and academia. Looking back at their own experiences, they will also share with us the opportunities and challenges around university-business collaboration and technology transfer. 

GUEST SPEAKERS: DR ALASDAIR TAYLOR & DR KATY GEARING

NEW BIOCHEMISTRY BUILDING, SOUTH PARKS RD, OX1 3QU - (6PM TO 7.30PM, FOCUS GROUP 5PM-5.55PM)

 

 

 

Dr Alasdair Taylor is Industry Programme Manager at the Royal Society. He has a research background in green chemistry, and has worked on collaborative projects between businesses and academics in the areas of energy storage, sustainable chemical engineering and food science. At the Royal Society, Alasdair is leading work focused on translation and developing an entrepreneurial mindset among scientists.  He is also Chair of the Royal Society of Chemistry’s Early Career Network.

https://uk.linkedin.com/in/alasdair-taylor-57a84125

Twitter: @AWTaylor8

Dr Katy Gearing studied biochemistry at St Catherine’s College, Oxford, graduating with a PhD in 1989. She has since worked extensively in industry in the fields of biotechnology and pharmaceuticals. She joined the Royal Society in 2016 as Head of Industry Engagement and is leading on growing the Society’s links with industry.

https://www.linkedin.com/in/katy-gearing-251888105

London Session 1: WHAT IT TAKES TO MAKE YOUR STARTUP A SUCCESS
Feb
23
6:30 pm18:30

London Session 1: WHAT IT TAKES TO MAKE YOUR STARTUP A SUCCESS

  • John Hanbury Lecture Theatre | UCL School of Pharmacy

 

Session 1: In this session participants will learn how to act on your great idea and build your business. Participants will leave knowing where to start and how to establish your first steps towards success. Crucial steps such as selection of a team, investigation of the potential associated risks and critical analysis of your business model will be covered.

Guest Speaker: Simon Bennett (Consultant)

Dr. Simon Bennett is an independent consultant with over 20 years of biotech industry experience. He mentors and advises early-stage businesses and management teams, and has senior management experience from start-up through to IPO and trade sale. Simon currently manages the portfolios of around 10 companies and is board director of MitoDys Therapeutics and colwiz.

Cambridge Session 1: Future CARE: AI Technology in Health
Jan
25
7:00 pm19:00

Cambridge Session 1: Future CARE: AI Technology in Health

  • Mong Hall

This event will be looking at how the relatively recent technology boom is affecting and changing the age old practice of medicine. This follows the the shift in healthcare to prioritising quality of life intended to support treatments, rather than treatments alone. We will be discussing how to begin to approach the biggest problems using technology tools. Looking into which challenges to target first, as well as the development of such projects. Further more, how will this fast paced field change in the coming years? Join us for an exciting event which looks into the changing landscape of healthcare.

Speaker: Cecily Morrison - Researcher at Microsoft

Cecily Morrison is a researcher in the Human Experience & Design (HXD) group at Microsoft Research Cambridge. Her research lies at the intersection of Human-Computer Interaction and Artificial Intelligence. Working in a cross-disciplinary collaboration, my current focus is on AI applications for those with visual disabilities. Ongoing projects include Torino (a physical programming language inclusive of children with visual disabilities) and Assess MS (a system to support the tracking of disease progression in patients with Multiple Sclerosis). Cecily holds a PhD in Computer Science from University of Cambridge and an undergraduate degree in Ethnomusicology from Barnard College, Columbia University.

London Session 4: Turning scientific research into a business
Dec
1
6:00 pm18:00

London Session 4: Turning scientific research into a business

  • UCL School of Pharmacy

The Science Innovation Union is offering a groundbreaking bio-entrepreneurship course aimed directly at the UK’s top scientists and budding entrepreneurs. The programme consists of a series of four exciting sessions lead by high profile leading academics and industry experts. Head to our website to sign up now! http://science-union.org/siu360-application

Links to other three session in the SIU360 series:
Session 1: https://www.facebook.com/events/1632034013488876/
Session 2: https://www.facebook.com/events/549654898557804/
Session 3: https://www.facebook.com/events/1653754461601574/

Session 4: In the final session of the series we explore the process of creating translational start-ups and technologies. Attendees will discover the life-cycle of a start-up and the hurdles that must be overcome. Additionally, risk-assessment and idea development will be explored.

Speaker: Matthew Durdy
Matthew joined the Cell and Gene Therapy Catapult in 2012, from the novel therapeutics company Aqix, where he was Chief Executive. He has broad experience in the biotechnology industry leading SMEs, raising finance and commercialising diagnostics, medical devices, and therapeutics for regulated use in the EU. He was also an expert advisor to the World Health Organisation on medical innovation strategy. Matthew was also a Director at the venture capital firm CDC, where he was responsible for due diligence and new investment in their $3.5bn international portfolio.

Oxford Session 4: Fates of successfully translated technologies
Nov
29
7:00 pm19:00

Oxford Session 4: Fates of successfully translated technologies

  • Saïd Business School, University of Oxford

The Science Innovation Union is offering a groundbreaking bio-entrepreneurship course aimed directly at the UK’s top scientists and budding entrepreneurs. The programme consists of a series of four exciting sessions lead by high profile leading academics and industry experts. Head to our website to sign up now! http://science-union.org/siu360-application

Links to other three session in the SIU360 series:
Session 1: https://www.facebook.com/events/636423359851397/
Session 2: https://www.facebook.com/events/1282123598478793/
Session 3: https://www.facebook.com/events/103430890126308/

Session 4: Fates of successfully translated technologies
In the final session of the series we explore the fates of successful start-ups and technologies. When is licencing your technology to an already established company in your sector a better route forward and when is the time right to float. Why does there seem to be a tendency for British firms in particular to be acquired by larger foreign organisations? When can this be the best outcome? We evaluate which are the most appropriate way to get your technology into the hands of those who would use it, and look at case studies of successful start-ups who have chosen each of these routes.
.
Speaker: Brian Graves
Brian joined Imperial Innovations in 2001 as head of the Engineering Technology Transfer team having previously gained over 20 years' experience in business development, product development and marketing in the engineering industry with John Crane Limited, a division of Smiths Group plc

London Session 3: Gaining the support of large organisations
Nov
21
6:00 pm18:00

London Session 3: Gaining the support of large organisations

  • UCL SCHOOL OF PHARMACY

The Science Innovation Union is offering a groundbreaking bio-entrepreneurship course aimed directly at the UK’s top scientists and budding entrepreneurs. The programme consists of a series of four exciting sessions lead by high profile leading academics and industry experts. Head to our website to sign up now! http://science-union.org/siu360-application

Links to other three session in the SIU360 series:
Session 1: https://www.facebook.com/events/1632034013488876/
Session 2: https://www.facebook.com/events/549654898557804/
Session 4: https://www.facebook.com/events/104791129993224/

Session 3: Findings through scientific research can be grand. In an academic environment, these high impact findings may not necessarily reach the public, even though it may directly affect this audience. Collaborating with large organisations, biotech companies, and the government may jump this hurdle. In this session, attendes will learn how to pitch outreach ideas to these organisations, and how to highlight benefits to that organisation in participating in translating scientific research that may not necessarily be a product of their institution. 

Speaker: Tijana Duric. 
GSK is working with many partners to eliminate and control some of the neglected tropical diseases. Tijana has been with GSK for 7 years, enetering as a supply chain manager. Her role now is tailored towards private-public partnerships and global health. Tijana looks after the supply planning for albendazole, a treatment for a variety of parasitic worm infections.

Oxford Session 3: Quelling fears; runways, risks and expectations
Nov
15
7:00 pm19:00

Oxford Session 3: Quelling fears; runways, risks and expectations

  • Saïd Business School, University of Oxford

The Science Innovation Union is offering a groundbreaking bio-entrepreneurship course aimed directly at the UK’s top scientists and budding entrepreneurs. The programme consists of a series of four exciting sessions lead by high profile leading academics and industry experts. Head to our website to sign up now! http://science-union.org/siu360-application

Links to other three session in the SIU360 series:
Session 1: https://www.facebook.com/events/636423359851397/
Session 2: https://www.facebook.com/events/1282123598478793/
Session 4: https://www.facebook.com/events/359868271018146/

Session 3: Quelling fears; runways, risks and expectations.
Translational scientists at the very beginning of their careers face a choice, do they elect to stay in academia and to some extent minimize their involvement in the running of their start-up, or if presented with the opportunity, should they take on the start-up as a full time occupation. The prospect of translating research into commercially useful products has its risks, indeed the statistics on success rates of start-ups are superficially quite alarming, but is taking on a postdoctoral position really much less risky? After all the proportion of PhD students that end up in a permanent academic position is also very low. Here we will explore the different areas of risk along the trajectory of a new start-up, from securing protected IP, to gathering funding, developing a technology to choosing the right people. If a young scientist decides to take on an idea and decides to develop the start up as their full time position how does one set appropriate targets by which to judge progress and succes. If the project ultimately ends in failure from a business point of view, where does that leave the founder? What’s next? What are the benefits of being fully involved in your start up, whether it succeeds or fails, from both a learning, enjoyment and scientific point of view?
.

Speaker: Steven Zimmer
Trained as a Biochemist and Molecular Biologist, Steven has had a long career as an analyst, investment banker and portfolio manager on Wall Street and in the City of London. He was a co-founder, Protein Sciences Inc., Steribottle Ltd and Tissuomics and has been an investor and advisor to many ventures and companies over the past 30 years. His latest position was as an advisor on Business and Strategic Development at e-Therapeutics plc, an AIM-listed network pharmacology-based drug discovery company based in Newcastle, UK.

London Session 2: Developing strategies for public engagement
Nov
3
6:00 pm18:00

London Session 2: Developing strategies for public engagement

  • Imperial College London

The Science Innovation Union is offering a groundbreaking bio-entrepreneurship course aimed directly at the UK’s top scientists and budding entrepreneurs. The programme consists of a series of four exciting sessions lead by high profile leading academics and industry experts. Head to our website to sign up now! http://science-union.org/siu360-application

Links to other three session in the SIU360 series:
Session 1: https://www.facebook.com/events/1632034013488876/
Session 3: https://www.facebook.com/events/1653754461601574/
Session 4: https://www.facebook.com/events/104791129993224/

Session 2: Developing strategies for public engagement.
Sharing great science with an audience can be a difficult task when raised in the lab environment and trained to publish in scientific journals. Where can scientific outreach be taken? What is the best way to convey research to a non-scientific audience? How is a public outreach event planned and organised? What language needs to be used for the proposed science to be understood by a wide audience and how can the importance of this science be made clear? In this session speakers will demonstrate strategic plans for creating public outreach events. Attendees will learn how to build an image of their work that will be clear and engaging for a wide audience. 

Speaker: Steven Zimmer, BSc(Hon), MSc.-Founder, Director and CEO - MitoDys Therapeutics

Steven trained as a Biochemist and Molecular Biologist, Steven has had a long career as an analyst, investment banker and portfolio manager on Wall Street and in the City of London. He was a co-founder, Protein Sciences Inc., Steribottle Ltd and Tissuomics and has been an investor and advisor to many ventures and companies over the past 30 years. His latest position was as an advisor on Business and Strategic Development at e-Therapeutics plc, an AIM-listed network pharmacology-based drug discovery company based in Newcastle, UK.

Oxford Session 2: Company structure, what is your role?
Nov
1
7:00 pm19:00

Oxford Session 2: Company structure, what is your role?

  • Saïd Business School, University of Oxford

The Science Innovation Union is offering a groundbreaking bio-entrepreneurship course aimed directly at the UK’s top scientists and budding entrepreneurs. The programme consists of a series of four exciting sessions lead by high profile leading academics and industry experts. Head to our website to sign up now! http://science-union.org/siu360-application

Links to other three session in the SIU360 series:
Session 1: https://www.facebook.com/events/636423359851397/
Session 3: https://www.facebook.com/events/103430890126308/
Session 4: https://www.facebook.com/events/359868271018146/

Session 2: Company sturcture, what is your role?
For many researchers, starting a company can be an exciting and immersive experience, however it is also one with heavy time and resource demands. As the majority of translational academic scientists will already have full time positions (either as staff of students), how can one run a company and maintain the high standard of work and dedication expected of their permanent position? Start-ups must be very dynamic and adaptable enterprises, and consequently the role of the founding scientist clearly changes dramatically over the time course of a company. Here we will look at the structure of a start-up and how this structure changes over time through the course of developing a start up from the early stages of just an idea, to an organisation gathering investment with a dedicated managerial team all the way to a profit making private or public company.

Speakers: Professor Jonathan Seville, Adrian Griffiths and Kevin Marks

Professor Seville is the Executive Dean of the Faculty of Engineering and Physical Sciences at the University of Surrey. He holds degrees in Chemical Engineering from the university of Cambridge and the University of Surrey and is a Fellow of the Institution of Chemical Engineers and a Fellow of the Royal Academy of Engineering. Professor Seville has an impressive record in the application of his science in the manufacturing of products in numerous industries, working with an extensive list of some of the largest companies in science, including Astra Zeneca, BP, Siemens and Unilever to name just a few. He also co-founded the successful spin-out company Recycling Technologies, of which he now sits on the advisory panel.

Adrian Griffiths is the current managing director of Recycling Technologies Ltd, and has extensive commercial and technical experience in many manufacturing sectors. Adrian holds a Bachelor of Engineering from Imperial college London.

Kevin Marks is the Chief Operating Officer of Warwick Ventures, Warwick universities commercialisation technology transfer office. Kevin hold a Bachelor degree in Engineering Science and an MBA from Warwick University, as well as an MPhil in electrical engineering from the University of Birmingham.

London Session 1: Platforms for translating research
Oct
27
6:00 pm18:00

London Session 1: Platforms for translating research

  • UCL School of Pharmacy

The Science Innovation Union is offering a groundbreaking bio-entrepreneurship course aimed directly at the UK’s top scientists and budding entrepreneurs. The programme consists of a series of four exciting sessions lead by high profile leading academics and industry experts. Head to our website to sign up now! http://science-union.org/siu360-application

Links to other three session in the SIU360 series:
Session 2: https://www.facebook.com/events/549654898557804/
Session 3: https://www.facebook.com/events/1653754461601574/
Session 4: https://www.facebook.com/events/104791129993224/

Session 1: Platforms for translating research.
For many scientists, translating research means publishing their work in a journal. These publications are critical in advancing our knowledge, however, a non-scientist audience would find it difficult to interpret these findings, and may therefore be excluded from the advancements scientist are achieving, which may be directly linked to the benefit of the public! In this session, the focus will be held on finding appropriate platforms for getting research known to the public. What organised events exist for bringing ideas forward? How to portray research so that it makes sense to a non-scientist? What are the best ways for exposing science to gain the largest impact? 

Speaker: Dr Amir Gander is the lead individual for Tissue Access for Patient Benefit (TAPb), a UCL initiative to bring surplus human tissue from surgery and biobanks to researchers across UK and internationally. Amir was involved with quality management and regulations and also specialised in the development of bench scale drug fermentation techniques to large production scales at a leading pharmaceutical production plant. TAPb has established a network of researchers interested in tissue from specific disease pathways. In collaboration with the state-of-the-art biobank at the Royal Free Hospital London, they have started to supply tissue (with clinical information) to a number of research companies and have strong ties with public and private sector researchers.

 Oxford Session 1: Opportunity recognition and construction
Oct
18
7:00 pm19:00

Oxford Session 1: Opportunity recognition and construction

  • Saïd Business School, University of Oxford

The Science Innovation Union is offering a groundbreaking bio-entrepreneurship course aimed directly at the UK’s top scientists and budding entrepreneurs. The programme consists of a series of four exciting sessions lead by high profile leading academics and industry experts. Head to our website to sign up now! http://science-union.org/siu360-application

Links to other three session in the SIU360 series:
Session 2: https://www.facebook.com/events/1282123598478793/
Session 3: https://www.facebook.com/events/103430890126308/
Session 4: https://www.facebook.com/events/359868271018146/

Session 1: Opportunity recognition and construction.
For those individuals at the start of their entrepreneurial career, one of the most difficult challenges is to learn how to spot opportunities that are worth chasing. Is there a demand? Is the proposed solution appropriate and economically viable? Is the timing right? Is the technology protectable from an IP point of view? This list of questions, which is far from exhaustive, are all questions which clearly need to be addressed, however the answers are not always obvious. Attendees will acquire knowledge and skills which will aid them in their assessment of opportunities and allow them to make better decisions when considering which ideas represent realistic and compelling opportunities.

Speaker: Chas Bountra is Professor of Translational Medicine in the Nuffield Department of Clinical Medicine and Associate Member of the Department of Pharmacology at the University of Oxford. He is also a Visiting Professor in Neuroscience and Mental Health at Imperial College, London. He is an invited expert on several government and charitable research funding bodies, and an advisor for many academic, biotech and pharma drug discovery programmes.

Prior to coming back to Oxford, Chas Bountra was Vice President and Head of Biology at GlaxoSmithKline. He was involved in the identification of more than 40 clinical candidates for many gastro-intestinal, inflammatory and neuro-psychiatric diseases.